2FIRSTS Interview with MVCC: License System Analysis, Recommend Building Business in Malaysia

Market by 2FIRSTS, edited by Sophia
May.10.2024
2FIRSTS Interview with MVCC: License System Analysis, Recommend Building Business in Malaysia
China's e-cigarette exports to Malaysia were valued at $21.72 million in February 2024, raising questions about upcoming regulations.

Malaysia, with a population of 33.94 million, is not only a populous country in Southeast Asia but also a major consumer of e-cigarettes. China has a huge export quantity of e-cigarettes to Malaysia, with exports reaching approximately 21.72 million US dollars in February 2024. Whether it's vape, heated e-cigarettes, nicotine pouches, or other novel tobacco products, the Malaysian market shows considerable potential.

 

Recently, there has been a viral rumor that Malaysia is planning to introduce a licensing system for e-cigarettes, where holding a local Electronic Vape Liquid/Gel Production License will become the standard for operating in the market. Some companies have already obtained these licenses, but is this true? As Malaysia prepares for a period of intensive regulatory implementation in 2023, which direction will the recent compliance regulations take? For Chinese companies looking to enter the Malaysian market and achieve success locally, what can they do? To answer these questions, 2FIRSTS conducted an interview with Ridhwan Rosli, the Secretary-General of the Malaysian Vape Chamber of Commerce.

 

Malaysia will implement a "license system," where an e-cigarette license (Electronic Vape Liquid/Gel Production License) will become the standard for regulating the market.

 

Secretary-General Ridhwan Rosli stated that currently, overall, any single license/permit cannot guarantee that a company is fully legal and compliant with e-cigarette-related laws in Malaysia.

 

In general, Malaysia's regulation of e-cigarettes is similar to that of other food and drug consumer products, divided into three levels: federal, state, and local. These three levels are relatively independent of each other, with their own legislative proposals and mechanisms for approval, and enforcement is also largely separate. Therefore, in order to comply with regulations in Malaysia, companies need to ensure compliance at all three levels.

 

How credible is the article about "INGOO" published on "The Page"?

 

Based on the above reasons, the article mentioned that "INGOO International team has become the first company in Malaysia to obtain a license for the full production and sale of e-cigarettes," but Ridhwan Rosli expressed skepticism about this claim. The concept of a "full production and sale license for e-cigarettes" is merely a vague idea. To his knowledge, no formal proposals have been submitted in writing from any party.

 

During the year 2024, the topic of discussion was the e-cigarette shop licensing system. This idea was proposed by Malaysia's former Health Minister Khairy Jamaluddin. Current Health Minister Dzulkefly Ahmad announced that he will be submitting a memorandum to the cabinet regarding regulatory suggestions based on the Public Health (Control of Smoking Product) Act 2024, proposed under the 852nd act. In the memorandum, former minister Khairy Jamaluddin suggested that the government should introduce a licensing system to restrict the sale of e-cigarettes to licensed specialty stores.

 

Ridhwan Rosli stated that it is possible for the companies mentioned in the article to have or be similar to traditional tobacco manufacturers with a "nicotine product license".

 

In which direction will Malaysia's compliance regulations develop in the near future?

 

In January 2023, the Malaysian Ministry of Health announced during a meeting with the Malaysian e-cigarette association that they are considering implementing a product-based approval system. Reidwan Rosli explained to 2FIRSTS that this approval system will be similar to the Pre-Market Tobacco Application (PMTA) introduced by the US Food and Drug Administration (FDA).

 

The product approval system is still under review. Reedwan-Rosli emphasized that even though domestic transactions in Malaysia are high and the black market is extensive, implementing the system and enforcing it will be a long process. However, the Malaysian e-cigarette association is working to establish a traceability mechanism for individual products to protect consumer rights.

 

What advice do you have for Chinese companies looking to enter the Malaysian market?

 

Ridhwan Rosli told 2FIRSTS that the chamber welcomes Chinese e-cigarette companies to develop and expand their market in Malaysia, a densely populated and potential-rich market. However, he also feels that the Chinese companies he has come across lack professionalism. He cited examples such as British American Tobacco (BAT), Philip Morris International (PMI), and Japan Tobacco International (JTI), which have been able to quickly establish distribution channels and dominate shelves in Malaysia, a "non-core" market, because they have built a professional team familiar with the local situation, market, and regulations. On the other hand, Chinese e-cigarette companies in Malaysia are mainly focused on "exporting to Malaysia" and have a sales-oriented approach, which Warren-Rossley believes lacks professionalism.

 

Ridhwan Rosli reminded that the lack of a professional team can result in significant hidden costs. For example, when applying for licenses, considerations such as the order of applying for multiple licenses and which state may have easier regulations for a certain type of license all require prior research and investment, or else companies may face various regulatory hurdles. Van-Rossley cited a real-life example where he encountered several Chinese e-cigarette companies wanting to host e-cigarette events, only to be temporarily shut down due to local regulations that did not allow it. These situations were all caused by a lack of understanding of local information.

 

During an interview with 2FIRSTS, he suggested that Chinese companies looking to enter the Malaysian market should consider establishing a local company in Malaysia. This would not only reduce the need for multiple licenses but also allow them to operate as a local business, streamline their sales channels, build their brand reputation, and establish good relationships with local regulatory authorities. He pointed out that this is also the approach taken by big companies like BAT and JTI. "Just by having an office," he mentioned, these e-cigarette companies can take control of their operations, reduce friction costs, and move forward smoothly.

 

Regarding Ridhwan Rosli

 

Ridhwan Rosli is a Malaysian entrepreneur with a strong interest in academia and civil society, holding both a bachelor's and master's degree. His academic contributions include co-authoring two books and publishing multiple articles in journals. Currently, he holds strategic positions as a shareholder and director in several public limited companies and private companies, spanning various industries. These companies include the Malaysian E-cigarette Association and Permodalan Tanah Melayu Berhad (TMCB), which was established in 2017.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
Imperial Brands' NGP Revenue Rises 11.4% in FY2026 but Business Still Posts £63 Million Loss; Zone Reaches 114,000 US Stores as Smokeless Reporting Takes Shape
Imperial Brands' NGP Revenue Rises 11.4% in FY2026 but Business Still Posts £63 Million Loss; Zone Reaches 114,000 US Stores as Smokeless Reporting Takes Shape
Imperial Brands reported an 11.4% increase in next-generation product (NGP) net revenue to £419 million in fiscal 2026, while its adjusted NGP operating loss narrowed to £63 million. European NGP revenue rose 16.8%, while the Americas recorded a 17.1% decline. Global modern oral nicotine volumes increased 27.8%, with US nicotine pouch brand Zone expanding to approximately 114,000 stores. The company also acquired Black Buffalo in the US and Helwit in Sweden, broadening its oral nicotine portfolio. From FY2027, Imperial Brands will adopt a new Smokeless reporting category combining NGP with traditional oral tobacco. On the new basis, FY2026 Smokeless net revenue was £554 million, with adjusted operating profit of £14 million.
company
Nov.18
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden's Public Health Agency has found ingredient labels on ZYN nicotine pouches sold by Philip Morris International subsidiary Swedish Match to be noncompliant, according to Dagens industri. The products' packaging listed 10 to 13 ingredients, compared with 11 to 42 in regulatory submissions, with multiple flavoring ingredients grouped under the generic term "aromer." The agency ordered corrective action, warning of a conditional penalty of SEK 2 million per month for noncompliance. The order applies only to products manufactured after the decision becomes legally effective and does not require recalls. Swedish Match disputes the agency's interpretation and plans to appeal.
PMI
Oct.22
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's Ministry of Gender Equality and Family said on September 14 that it plans to designate unmanned e-cigarette stores as businesses where minors are prohibited from entering or working. Operators would be required to verify customers' ages and display notices restricting access by minors. The proposal is open for public comment through October 6. The move follows an April expansion of South Korea's statutory tobacco definition that brought products made with natural or synthetic nicotine under the Tobacco Business Act. Nicotine-free liquids and products using nicotine analogues such as 6-methylnicotine, however, remain an emerging regulatory issue.
Sep.21
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22